相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Further TWEAK to Multiple Sclerosis Pathophysiology
Arash Nazeri et al.
MOLECULAR NEUROBIOLOGY (2014)
TWEAK prevents TNF-α- induced insulin resistance through PP2A activation in human adipocytes
Ana Vazquez-Carballo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
The TWEAK-Fn14 system as a potential drug target
Harald Wajant
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis
Nicolas Wisniacki et al.
CLINICAL THERAPEUTICS (2013)
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Steffen Salzmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging
Andreas Thalheimer et al.
JOURNAL OF SURGICAL RESEARCH (2013)
TNF-Like Weak Inducer of Apoptosis (TWEAK) Promotes Beta Cell Neogenesis from Pancreatic Ductal Epithelium in Adult Mice
Fei Wu et al.
PLOS ONE (2013)
Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling
Thomas G. Bird et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
S. Bhatnagar et al.
CURRENT MOLECULAR MEDICINE (2012)
Role of TWEAK in lupus nephritis: A bench-to-bedside review
Jennifer S. Michaelson et al.
JOURNAL OF AUTOIMMUNITY (2012)
The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
Taeko Dohi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system
Ramiro Echeverry et al.
JOURNAL OF NEUROINFLAMMATION (2012)
The role of TWEAK/Fn14 in cardiac remodeling
Man-Yi Ren et al.
MOLECULAR BIOLOGY REPORTS (2012)
Abstract C18: A phase I study of enavatuzumab (PDL192, ABT-361), a first-in-class human monoclonal antibody targeting TWEAK (tumor necrosis factor-like inducer of apoptosis) receptor, in patients (Pts) with advanced solid tumors.
E. T. Lam et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma
Simone S. Riedel et al.
PLOS ONE (2012)
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Linda C. Burkly et al.
IMMUNOLOGICAL REVIEWS (2011)
TWEAK Induces Apoptosis through a Death-signaling Complex Comprising Receptor-interacting Protein 1 (RIP1), Fas-associated Death Domain (FADD), and Caspase-8
Aminah Ikner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S. Michaelson et al.
MABS (2011)
Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
Patricia A. Culp et al.
CLINICAL CANCER RESEARCH (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer
Andreas Thalheimer et al.
BMC CANCER (2009)
TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling
A. Wicovsky et al.
CELL DEATH AND DIFFERENTIATION (2009)
Pro-Inflammatory Cytokines TNF-Related Weak Inducer of Apoptosis (TWEAK) and TNFα Induce the Mitogen-Activated Protein Kinase (MAPK)-Dependent Expression of Sclerostin in Human Osteoblasts
Cristina Vincent et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting
Jeffrey A. Winkles
NATURE REVIEWS DRUG DISCOVERY (2008)
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome
Nhan L. Tran et al.
CANCER RESEARCH (2006)
TWEAK is a novel arthritogenic mediator
Stuart J. Perper et al.
JOURNAL OF IMMUNOLOGY (2006)
Engineered antibody Fc variants with enhanced effector function
GA Lazar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Multiple pathways of TWEAK-Induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
